All Stories

  1. Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

    Article • Journal of Hepatocellular Carcinoma, November 2019, Taylor & Francis

    Mohamed El Kassas

  2. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

    Article • Expert Review of Gastroenterology & Hepatology, August 2019, Taylor & Francis

    Shereen Abdel Alem, Aisha Elsharkawy , Yehia El Shazly, Mohamed El Kassas, dina ziada

  3. High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

    Article • Expert Review of Gastroenterology & Hepatology, June 2019, Taylor & Francis

    Professor Kadry Elsaeed, Dr Heba Omar, Mohamed Shaker , Yehia El Shazly, Mohamed El Kassas

  4. Diabetes association with liver diseases: an overview for clinicians

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, November 2018, Bentham Science Publishers

    Nadia Elwan, sherief Abd-Elsalam, Mohamed El Kassas, Abd Elkhalek Hamed, Reda Elwakil

  5. Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Mohamed El Kassas, Naglaa Youssef

  6. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data

    Article • Liver International, May 2018, Wiley

    Mohamed El Kassas, Samy Zaky

  7. A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: Ravidasvir

    Article • Current Drug Discovery Technologies, April 2018, Bentham Science Publishers

    Mohamed El Kassas

  8. Professor of Internal Medicine, Consultant Hepatologist

    Article • Alimentary Pharmacology & Therapeutics, November 2017, Wiley

    Mohamed El Kassas, Dr Heba Omar, Professor Monkez M Yousif

  9. After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal

    Article • Journal of Clinical Laboratory Analysis, July 2017, Wiley

    Mohamed El Kassas, Dr Mohamed Alboraie

  10. HCV in EGYPT

    Article • Hepatic Medicine Evidence and Research, July 2017, Dove Medical Press

    Aisha Elsharkawy , Mohamed El Kassas

  11. Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection

    Article • Expert Opinion on Drug Discovery, May 2017, Taylor & Francis

    Mohamed El Kassas

  12. Hepatitis C infection in Egypt: prevalence, impact and management strategies

    Article • Hepatic Medicine Evidence and Research, May 2017, Dove Medical Press

    Aisha Elsharkawy , Mohamed El Kassas

  13. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

    Article • Journal of Viral Hepatitis, February 2017, Wiley

    Dr Marwa Khairy, Mohamed El Kassas

  14. Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

    Article • Liver International, November 2016, Wiley

    Mohamed El Kassas